Gryska David W's Form 4 filing
Seagen Inc. (SGEN) · filed Feb 9, 2022
- Accession no.
- 0001203311-22-000013
- Filed
- Feb 9, 2022
- Trade date
- Feb 7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $624.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gryska David WCIK 0001202335 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +1,100 | $20.06 | +$22,066 | 47,350 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −1,100 | $137.45F3 | −$151,195 | 46,250 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +1,029 | $20.06 | +$20,641.74 | 47,279 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −1,029 | $138.66F4 | −$142,681.14 | 46,250 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +2,371 | $20.06 | +$47,562.26 | 48,621 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −2,371 | $139.42F5 | −$330,564.82 | 46,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −1,100 | $0.00 | $0 | 7,400 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −1,029 | $0.00 | $0 | 6,371 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −2,371 | $0.00 | $0 | 4,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $137.03 to $137.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $138.03 to $139.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects sales of common stock executed in multiple transactions at prices ranging from $139.20 to $139.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.